Abstract | OBJECTIVE: The pathway by which herpes simplex virus 2 (HSV2) triggers the innate immune system in the urogenital system has not as yet been fully elucidated. In this study, we aimed to determine which pattern recognition receptors ( PRRs) recognize HSV2 in primary vaginal epithelial cells. Once we deciphered the receptors involved, we aimed to target them to immunomodulate innate responses as a prophylactic or therapeutic intervention for early HSV2 infection. STUDY DESIGN: To determine which PRRs are involved, receptor silencing as well as confocal microscopy was utilized. For immunomodulation, PRR agonists were utilized to induce a strong, local response to limit the infection, and we used 2 quantitative methods, flow cytometry and plaque assays, to determine their effect on HSV2 replication. RESULTS: CONCLUSION: Different PRRs are strategically placed in different cell locations to detect virus invasion. Use of agonists that target and activate these PRRs appeared to be effective in preventing primary HSV2 infection in vaginal cells and could provide new insights in defense against HSV2 urogenital infections.
|
Authors | Kathy Triantafilou, Dilan Eryilmazlar, Martha Triantafilou |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 210
Issue 2
Pg. 122.e1-122.e10
(Feb 2014)
ISSN: 1097-6868 [Electronic] United States |
PMID | 24080302
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 Mosby, Inc. All rights reserved. |
Chemical References |
- DNA-Binding Proteins
- Nuclear Proteins
- Phosphoproteins
- RNA-Binding Proteins
- Toll-Like Receptor 2
- Toll-Like Receptor 9
- ZBP1 protein, human
- IFI16 protein, human
|
Topics |
- DNA-Binding Proteins
(physiology)
- Female
- Herpes Genitalis
(immunology, virology)
- Herpesvirus 2, Human
(physiology)
- Humans
- Immunity, Innate
- Nuclear Proteins
(physiology)
- Phosphoproteins
(physiology)
- RNA-Binding Proteins
- Toll-Like Receptor 2
(physiology)
- Toll-Like Receptor 9
(physiology)
- Vagina
(immunology, virology)
- Virus Activation
(physiology)
|